CLAIM CARD
Quantitative findings from this trial are characterized by a mixture of null and highly significant results across different measured endpoints. However, other endpoints demonstrated strong statistical significance, with P < 0.0001 and P < 0.001 reported. The full distribution of per-study endpoint evidence, including the specific biomarkers associated with these p-values, is detailed in Table 2.
Evidence grade: exploratory
Contradiction status: none
Publication: edeb045d-18ed-49dc-95b6-57f76783ce2b
Provenance: Derivation Web chain
Citation Support
source_1Solomon 2026source_2Din 2026source_3Li 2025source_4Mei 2025source_5Chung 2024